Stocks Health care CNBX
OTC · Health careCNBX Pharmaceuticals Inc. (CNBX)
CNBX Pharmaceuticals Inc. brought in $0 of revenue over the twelve months to May 31, 2026. It posted a net loss of $462.1K. At May 31, 2026 it held $9.5K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on June 24, 2026.
Watch CNBX in 60 secondsWhat CNBX Pharmaceuticals Inc. does
CNBX Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CNBX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$314K | $0.00 | n/a |
| 2024 | $130.1K | -$695.2K | -$0.02 | n/a |
| 2023 | $410.2K | -$3.7M | -$0.42 | n/a |
| 2022 | $30K | -$3.7M | -$3.59 | n/a |
| 2021 | $0 | -$3.2M | -$0.02 | n/a |
| 2020 | $7.2K | -$7.5M | -$0.10 | n/a |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What CNBX Pharmaceuticals Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- June 24, 2026
- May 8, 2026Passive stake changed SCHEDULE 13G/A
- April 14, 2026
- March 17, 2026
- February 5, 2026Passive stake changed SCHEDULE 13G/A
- January 14, 2026
- December 1, 2025
- November 10, 2025Passive stake changed SCHEDULE 13G/A
- August 13, 2025Passive stake changed SCHEDULE 13G/A
Who owns CNBX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| 3i, LP13G, passive with 2 related filers | 9.9% | August 14, 2026 |
Largest institutional holders
Insiders
Questions about CNBX
What does CNBX Pharmaceuticals Inc. do?
CNBX Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker CNBX.
Is CNBX Pharmaceuticals Inc. profitable?
No. Over the twelve months to May 31, 2026 it reported a net loss of $462.1K.
How much revenue does CNBX Pharmaceuticals Inc. make?
Over the twelve months to May 31, 2026 CNBX Pharmaceuticals Inc. reported revenue of $0.
When did CNBX Pharmaceuticals Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on June 24, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Compare CNBX with
Follow CNBX
Get an email when CNBX Pharmaceuticals Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CNBX: get an email when it filesWhere the numbers come from
Financial figures are the values CNBX Pharmaceuticals Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.